Stay up-to-date on our latest news and find resources for journalists.
Oct 20, 2025
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
Oct 14, 2025
Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults
Jun 17, 2025
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
Mar 24, 2025
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019